Hugues Beauregard

1.9k total citations
26 papers, 1.4k citations indexed

About

Hugues Beauregard is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Neurology. According to data from OpenAlex, Hugues Beauregard has authored 26 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Endocrinology, Diabetes and Metabolism, 10 papers in Surgery and 4 papers in Neurology. Recurrent topics in Hugues Beauregard's work include Pituitary Gland Disorders and Treatments (18 papers), Growth Hormone and Insulin-like Growth Factors (10 papers) and Adrenal and Paraganglionic Tumors (10 papers). Hugues Beauregard is often cited by papers focused on Pituitary Gland Disorders and Treatments (18 papers), Growth Hormone and Insulin-like Growth Factors (10 papers) and Adrenal and Paraganglionic Tumors (10 papers). Hugues Beauregard collaborates with scholars based in Canada, Australia and Argentina. Hugues Beauregard's co-authors include Omar Serri, Jules Hardy, M Somma, Nahla Aris-Jilwan, R Comtois, E Rasio, André Lacroix, Sylvie Bertrand, Oscar D. Bruno and Hélène Fournier and has published in prestigious journals such as New England Journal of Medicine, The Journal of Clinical Endocrinology & Metabolism and Diabetes Care.

In The Last Decade

Hugues Beauregard

26 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hugues Beauregard Canada 17 1.2k 572 231 178 131 26 1.4k
John Ayuk United Kingdom 24 1.8k 1.5× 768 1.3× 369 1.6× 274 1.5× 77 0.6× 69 2.2k
Rosa Maria Paragliola Italy 18 669 0.6× 293 0.5× 188 0.8× 54 0.3× 84 0.6× 67 1.2k
Mattia Barbot Italy 25 1.4k 1.2× 703 1.2× 123 0.5× 132 0.7× 36 0.3× 84 1.6k
A. Stuart Mason United Kingdom 14 658 0.6× 167 0.3× 105 0.5× 38 0.2× 84 0.6× 43 999
F. D. Rosenthal United Kingdom 19 325 0.3× 169 0.3× 105 0.5× 37 0.2× 105 0.8× 48 913
Richard Paisey United Kingdom 20 901 0.8× 369 0.6× 85 0.4× 41 0.2× 722 5.5× 52 1.7k
M Leuténegger France 16 307 0.3× 209 0.4× 130 0.6× 18 0.1× 133 1.0× 57 1.0k
C. H. Walsh Ireland 14 201 0.2× 156 0.3× 72 0.3× 96 0.5× 112 0.9× 40 702
Mithat Bahçeci Türkiye 19 476 0.4× 117 0.2× 262 1.1× 21 0.1× 116 0.9× 61 1.2k
Raymond C. Mellinger United States 17 415 0.4× 131 0.2× 75 0.3× 23 0.1× 95 0.7× 51 857

Countries citing papers authored by Hugues Beauregard

Since Specialization
Citations

This map shows the geographic impact of Hugues Beauregard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hugues Beauregard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hugues Beauregard more than expected).

Fields of papers citing papers by Hugues Beauregard

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hugues Beauregard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hugues Beauregard. The network helps show where Hugues Beauregard may publish in the future.

Co-authorship network of co-authors of Hugues Beauregard

This figure shows the co-authorship network connecting the top 25 collaborators of Hugues Beauregard. A scholar is included among the top collaborators of Hugues Beauregard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hugues Beauregard. Hugues Beauregard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bourdeau, Isabelle, et al.. (2013). Pasireotide monotherapy in Cushing’s disease: a single-centre experience with 5-year extension of phase III Trial. Pituitary. 17(6). 519–529. 32 indexed citations
2.
Beauregard, Hugues, et al.. (2013). Iatrogenic Cushing Syndrome in Patients Receiving Inhaled Budesonide and Itraconazole or Ritonavir: Two Cases and Literature Review. Endocrine Practice. 19(6). e138–e141. 27 indexed citations
3.
Godbout, Ariane, Marcos Manavela, Karina Danilowicz, et al.. (2010). Cabergoline monotherapy in the long-term treatment of Cushing's disease. European Journal of Endocrinology. 163(5). 709–716. 147 indexed citations
4.
Vallette, Sophie, Karim Serri, Juan Rivera, et al.. (2008). Long-term cabergoline therapy is not associated with valvular heart disease in patients with prolactinomas. Pituitary. 12(3). 153–157. 83 indexed citations
5.
Chiasson, Jean‐Louis, Nahla Aris-Jilwan, Sylvie Bertrand, et al.. (2003). Diagnosis and treatment of diabetic ketoacidosis and the hyperglycemic hyperosmolar state.. PubMed. 168(7). 859–66. 203 indexed citations
6.
Massoud, Fadi, Omar Serri, Jules Hardy, M Somma, & Hugues Beauregard. (1996). Transsphenoidal adenomectomy for microprolactinomas: 10 to 20 years of follow-up. Surgical Neurology. 45(4). 341–346. 43 indexed citations
7.
Beauregard, Hugues, et al.. (1996). Surgical outcome after repeated transsphenoidal surgery in acromegaly. Journal of neurosurgery. 85(2). 239–247. 63 indexed citations
8.
Senécal, Jean‐Luc, Imad Uthman, & Hugues Beauregard. (1994). Cushing's disease‐induced remission of severe rheumatoid arthritis. Arthritis & Rheumatism. 37(12). 1826–1826. 18 indexed citations
9.
Comtois, R, Hugues Beauregard, Jules Hardy, Françoise Robert, & M Somma. (1993). High prolactin levels in patients with Cushing's disease without pathological evidence of pituitary adenoma. Clinical Endocrinology. 38(6). 601–607. 14 indexed citations
10.
Comtois, R, Hugues Beauregard, M Somma, et al.. (1991). The clinical and endocrine outcome to trans-sphenoidal microsurgery of nonsecreting pituitary adenomas. Cancer. 68(4). 860–866. 208 indexed citations
11.
Serri, Omar, Hugues Beauregard, Jacques Lesage, et al.. (1990). Long Term Treatment with CV 205–502 in Patients with Prolactin-Secreting Pituitary Macroadenomas*. The Journal of Clinical Endocrinology & Metabolism. 71(3). 682–687. 18 indexed citations
12.
Comtois, R, et al.. (1989). Technical and clinical evaluation of fructosamine determination in serum. Clinical Biochemistry. 22(4). 329–335. 12 indexed citations
13.
Comtois, R, et al.. (1989). Clinical usefulness of estimation of serum fructosamine concentration as screening test for gestational diabetes. American Journal of Obstetrics and Gynecology. 160(3). 651–654. 14 indexed citations
14.
Serri, Omar, Françoise Robert, Georges Pelletier, Hugues Beauregard, & Jules Hardy. (1987). Hyperprolactinemia associated with clinically silent adenomas: endocrinologic and pathologic studies; a report of two cases. Fertility and Sterility. 47(5). 792–796. 5 indexed citations
15.
Serri, Omar, Hugues Beauregard, E Rasio, & Jules Hardy. (1986). Decreased sensitivity to insulin in women with microprolactinomas. Fertility and Sterility. 45(4). 572–574. 28 indexed citations
16.
Maheux, Rodolphe, Milos Jenicek, Robert Cléroux, et al.. (1983). Oral Contraceptives and Prolactinomas. Obstetrical & Gynecological Survey. 38(1). 44–45. 1 indexed citations
17.
Maheux, Rodolphe, Milos Jenicek, Robert Cléroux, et al.. (1982). Oral contraceptives and prolactinomas: A case-control study. American Journal of Obstetrics and Gynecology. 143(2). 134–138. 25 indexed citations
18.
Hardy, Jules, Hugues Beauregard, & Françoise Robert. (1980). Prolactin-secreting Pituitary Adenomas: Transsphenoidal Microsurgical Treatment. Neurosurgery. 27(CN_suppl_1). 38–47. 57 indexed citations
19.
Jolivet, Jacques, Hugues Beauregard, M Somma, & Pierre R. Band. (1980). ACTH-secreting medullary carcinoma of the thyroid: Monitoring of clinical course with calcitonin and cortisol assays and immunohistochemical studies. Cancer. 46(12). 2667–2670. 11 indexed citations
20.
Campenhout, J. Van, et al.. (1977). Amenorrhea following the Use of Oral Contraceptives. Fertility and Sterility. 28(7). 728–732. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by John Ayuk Breakdown of academic impact, for papers by Rosa Maria Paragliola Breakdown of academic impact, for papers by Mattia Barbot Breakdown of academic impact, for papers by A. Stuart Mason Breakdown of academic impact, for papers by F. D. Rosenthal Breakdown of academic impact, for papers by Richard Paisey Breakdown of academic impact, for papers by M Leuténegger Breakdown of academic impact, for papers by C. H. Walsh Breakdown of academic impact, for papers by Mithat Bahçeci Breakdown of academic impact, for papers by Raymond C. Mellinger
Rankless by CCL
2026